A61K2039/625 - CPC Classification Index

#1

20250228923

2025-07-17

COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS

#2

20250188135

2025-06-12

A MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS)-BASED STAPHYLOCOCCUS AUREUS VACCINE COMPRISING B- AND T-CELL ANTIGENS, IMMUNOGENIC COMPOSITION, AND USES THEREOF

#3

20250114443

2025-04-10

PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE

#4

20250066429

2025-02-27

MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS

#5

20240425553

2024-12-26

MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF

#6

20240366738

2024-11-07

MOLECULAR VACCINES FOR INFECTIOUS DISEASE

#7

20240101613

2024-03-28

OLIGOMERIC PARTICLE REAGENTS AND METHODS OF USE THEREOF

#8

20240025952

2024-01-25

Modified biotin-binding protein, fusion proteins thereof and applications

#9

20240010657

2024-01-11

BIOTIN DERIVATIVES

#10

20230390385

2023-12-07

Compositions and Methods for Prevention and Treatment of Immune Complex Disease

#11

20230167157

2023-06-01

ANTIGENIC DETERMINANTS PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS PRECISION VACCINE AGAINST SARS-CoV-2

#12

20230081705

2023-03-16

Protein antigens that provide protection against pneumococcal colonization and/or disease

#13

20220072118

2022-03-10

Immunogenic compositions

#14

20210332090

2021-10-28

Multiple antigen presenting immunogenic composition, and methods and uses thereof

#15

20210032297

2021-02-04

Oligomeric particle reagents and methods of use thereof

#16

20200407404

2020-12-31

Modified biotin-binding protein, fusion proteins thereof and applications

#17

20200376108

2020-12-03

Comprehensive vaccine design for commensal disease progression

#18

20200261597

2020-08-20

BIOFUNCTIONALIZED NANOPARTICLES AND USES THEREOF IN ADOPTIVE CELL THERAPY

#19

20200171138

2020-06-04

VIRUS LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY

#20

20200121777

2020-04-23

Combined vaccine against mycobacterium tuberculosis

#21

20200095546

2020-03-26

Nanoscale artificial antigen presenting cells

#22

20190322681

2019-10-24

Biotin derivatives

#23

20190314471

2019-10-17

Molecular vaccines for infectious disease

#24

20190160161

2019-05-30

Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof

#25

20190119335

2019-04-25

Modified biotin-binding protein, fusion proteins thereof and applications

#26

20190022206

2019-01-24

Virus like particle with efficient epitope display

#27

20180280536

2018-10-04

Biofunctionalized nanoparticles and uses thereof in adoptive cell therapy

#28

20180092859

2018-04-05

A Supramolecular Chitosan Complex Drug Delivery Platform

#29

20160257947

2016-09-08

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#30

20160090404

2016-03-31

Modified biotin-binding protein, fusion proteins thereof and applications

#31

20160051698

2016-02-25

Nanoscale artificial antigen presenting cells

#32

20150374811

2015-12-31

Protein antigens that provide protection against pneumococcal colonization and/or disease

#33

20140161793

2014-06-12

Glycoconjugates and their use as potential vaccines against infection by

#34

20140154287

2014-06-05

Multiple antigen presenting immunogenic composition, and methods and uses thereof

#35

20140038261

2014-02-06

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#36

20130023059

2013-01-24

Method for immobilizing streptavidin on a self-assembled monolayer

#37

20120258126

2012-10-11

Molecular vaccines for infectious disease

#38

20120171240

2012-07-05

Immunostimulatory compositions and methods

#39

20120130050

2012-05-24

Biomolecule fixing board and method of manufacturing the same

#40

20110274704

2011-11-10

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

#41

20110236411

2011-09-29

MHC multimers in tuberculosis diagnostics, vaccine and therapeutics

#42

20110217307

2011-09-08

Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies

#43

20110189180

2011-08-04

Antigenic compositions and use of same in the targeted delivery of nucleic acids

#44

20110189083

2011-08-04

Dock-and-lock (DNL) vaccines for cancer therapy

#45

20110159037

2011-06-30

METHODS OF TREATING AND PROTECTING AGAINST HUMAN IMMUNODEFICIENCY VIRUS

#46

20110142874

2011-06-16

Compositions, Methods, and Kits for Eliciting an Immune Response

#47

20110020273

2011-01-27

Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof

#48

20100310592

2010-12-09

A TRUNCATED FORM OF THE HIV P17 PROTEIN

#49

20100240585

2010-09-23

IN VIVO CELL SURFACE ENGINEERING

#50

20100189641

2010-07-29

Strategies for improved cancer vaccines

#51

20100158936

2010-06-24

Immunostimulatory compositions and methods

#52

20100068137

2010-03-18

Dock-and-lock (DNL) vaccines for cancer therapy

#53

20100047331

2010-02-25

Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates

#54

20090239794

2009-09-24

HCV F PROTEIN AND USES THEREOF

#55

20090104268

2009-04-23

Nanoparticles comprising antigens and adjuvants, and immunogenic structures

#56

20090053261

2009-02-26

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

#57

20080274128

2008-11-06

Heat shock protein-based vaccines and immunotherapies

#58

20080112951

2008-05-15

Glycoconjugates and their use as potential vaccines against infection by

#59

20070184473

2007-08-09

Immunostimulatory compositions and methods

#60

20070172504

2007-07-26

In vivo cell surface engineering

#61

20060222652

2006-10-05

Molecular antigen array